In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response

Tsang, 2016, Stereotactic body radiotherapy: current strategies and future development, J Thorac Dis, 8, S517, 10.21037/jtd.2016.03.14 Petrelli, 2017, Stereotactic body radiation therapy for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials, Int J Radiation Oncol Biol Phys, 97, 313, 10.1016/j.ijrobp.2016.10.030 Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol, 14, e28, 10.1016/S1470-2045(12)70510-7 Rosenblatt, 2014, Planning national radiotherapy services, Front Oncol, 4, 10.3389/fonc.2014.00315 Dahele, 2016, Stereotactic body radiotherapy for spine and bony pelvis using flattening filter free volumetric modulated arc therapy, 6D cone-beam CT and simple positioning techniques: Treatment time and patient stability, Acta Oncol, 55, 795, 10.3109/0284186X.2015.1119885 Kragl, 2009, Dosimetric characteristics of 6 and 10MV unflattened photon beams, Radiotherapy Oncol, 93, 141, 10.1016/j.radonc.2009.06.008 Gasic, 2014, A treatment planning and delivery comparison of volumetric modulated arc therapy with or without flattening filter for gliomas, brain metastases, prostate, head/neck and early stage lung cancer, Acta Oncol, 53, 1005, 10.3109/0284186X.2014.925578 Spiotto, 2016, The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications, Sci Immunol, 1, 10.1126/sciimmunol.aag1266 Golden, 2015, Radiotherapy and immunogenic cell death, Seminars Radiation Oncol, 25, 11, 10.1016/j.semradonc.2014.07.005 Burnette, 2011, The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity, Cancer Res, 71, 2488, 10.1158/0008-5472.CAN-10-2820 Lim, 2014, Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells, Cancer Immunol Immunother, 63, 259, 10.1007/s00262-013-1506-7 Sistigu, 2014, Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy, Nat Med, 20, 1301, 10.1038/nm.3708 Vanpouille-Box, 2017, DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity, Nat Commun, 8, 15618, 10.1038/ncomms15618 Muroyama, 2017, Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment, Cancer Immunol Res, 5, 992, 10.1158/2326-6066.CIR-17-0040 Vatner, 2015, Myeloid-derived cells in tumors: effects of radiation, Seminars Radiation Oncol, 25, 18, 10.1016/j.semradonc.2014.07.008 Grapin, 2019, Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination, J Immunotherapy Cancer, 7, 160, 10.1186/s40425-019-0634-9 Sørensen, 2011, Dependence of cell survival on instantaneous dose rate of a linear accelerator, Radiother Oncol, 101, 223, 10.1016/j.radonc.2011.06.018 King, 2013, Anin vitrostudy of the radiobiological effects of flattening filter free radiotherapy treatments, Phys Med Biol, 58, N83, 10.1088/0031-9155/58/5/N83 Cerviño, 2019, An in vitro study for the dosimetric and radiobiological validation of respiratory gating in conventional and hypofractionated radiotherapy of the lung: effect of dose, dose rate, and breathing pattern, Phys Med Biol, 64, 10.1088/1361-6560/ab2940 Lasio, 2014, Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival, Radiat Environ Biophys, 53, 671, 10.1007/s00411-014-0565-2 Sarojini, 2015, A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes, Melanoma Res, 25, 376, 10.1097/CMR.0000000000000174 Dang, 2017, Efficacy of flattening-filter-free beam in stereotactic body radiation therapy planning and treatment: a systematic review with meta-analysis, J Med Imaging Radiation Oncol, 61, 379, 10.1111/1754-9485.12583 Végran, 2014, The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells, Nat Immunol, 15, 758, 10.1038/ni.2925 Bugaut, 2013, Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. Glod JW, ed., PLoS ONE, 8, 10.1371/journal.pone.0065181 Wolf, 2016, Short-term heat pre-treatment modulates the release of HMGB1 and pro-inflammatory cytokines in hPDL cells following mechanical loading and affects monocyte behavior, Clin Oral Invest, 20, 923, 10.1007/s00784-015-1580-7 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci, 102, 15545, 10.1073/pnas.0506580102 Favaudon, 2014, Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice, Sci Transl Med, 6, 10.1126/scitranslmed.3008973 Vozenin, 2019, The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients, Clin Cancer Res, 25, 35, 10.1158/1078-0432.CCR-17-3375 Bourhis, 2019, Treatment of a first patient with FLASH-radiotherapy, Radiother Oncol, 139, 18, 10.1016/j.radonc.2019.06.019 Chen, 2018, Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis, J Exp Clin Cancer Res, 37, 77, 10.1186/s13046-018-0726-2 Matsumura, 2008, Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells, J Immunol, 181, 3099, 10.4049/jimmunol.181.5.3099 Eckert, 2018, Potential role of CXCR4 targeting in the context of radiotherapy and immunotherapy of cancer, Front Immunol, 9, 3018, 10.3389/fimmu.2018.03018 Antonia, 2017, Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer, N Engl J Med, 10.1056/NEJMoa1709937 Galon, 2019, Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Nat Rev Drug Discov, 18, 197, 10.1038/s41573-018-0007-y